Hallucinogen-persisting perception disorder

Therapeutic Advances in Psychopharmacology

Volumn 2, Issue 5, 2012, Pages 199-205

  Hermle, Leo ^a   Simon, Melanie ^a   Ruchsow, Martin ^a   Geppert, Martin ^a  

^a Göppingen ^*  (Germany)

Author keywords

Flashback; hallucinogen persisting perception disorder; LSD

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; LAMOTRIGINE; LYSERGIDE; RISPERIDONE; SERTRALINE;

ADULT; CASE REPORT; DEPRESSION; DRUG ABUSE; DYSTHYMIA; FEMALE; HALLUCINOGEN PERSISTING PERCEPTION DISORDER; HUMAN; LETTER; MICROPSIA; NEUROPSYCHOLOGICAL TEST; PERCEPTION DISORDER; PRIORITY JOURNAL; TREATMENT DURATION; VISUAL DISORDER;

EID: 84997907965     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125312451270     Document Type: Letter

References (30)

1. Abraham H. (1982) A chronic impairment of colour vision in users of LSD. Br J Psychiatry 140: 518–520.
2. Abraham H. (1983) Visual phenomenology of the LSD flashback. Arch Gen Psychiatry 40: 884–889.
3. Abraham H. (2001) New hope for hallucinogen-induced persistent perceptual disorder? (letter). J Clin Psychopharmacol 21: 344.
4. Abraham H. Aldridge A.M. Gogia P. (1996) The psychopharmacology of hallucinogens. Neuropsychopharmacology 14: 285–298.
5. Abraham H. Mamen A. (1996) LSD-like panic from risperidone in post-LSD-visual disorder. J Clin Psychopharmacol 16: 238–241.
6. Alarcon R. Dickinson W. Dohn H. (1982) Flashback phenomena: clinical and diagnostic dilemmas. J Nerv Ment Dis 170: 217–223.
7. Alcantara A. (1998) Is there a role for the alpha2 antagonism in the exacerbation of hallucinogen-persisting perception disorder with risperidone? J Clin Psychopharmacol 18: 487–488.
8. Aldurra G. Crayton J. (2001) Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report. J Clin Psychopharmacol 21: 343–344.
9. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed. Washington DC: American Psychiatric Press
10. Bonson K. Buckholtz J. Murphy D. (1996) Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology 14: 425–436.
11. Cooper H. (1955) Hallucinogenic drugs. Lancet 1: 1078–1079.
12. Dilling H. Mombour W. Schmidt M. (Eds) (1991) Mental and Behavioural Disorders (Including Disorders of Psychological Development). Clinical Descriptions and Diagnostic Guidelines. In: Tenth Revision of the International Classification of Diseases, chapter V (F): Bern: Huber (German Translation).
13. Espiard M. Lecardeur L. Abadie P. Halbecq I. Dollfus S. (2005) Hallucinogen persisting disorder after psilocybin consumption: a case study. Eur Psychiatry 20: 458–460.
14. Halonen T. Nissinen J. Pitkänen A. (2001) Effect of lamotigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat. Epilepsy Res 46: 205–223.
15. Halpern J. (2003) Hallucinogens: an update. Curr Psychiatry Rep 5: 347–354.
16. Halpern J. Pope H.G. (2003) Hallucinogen persisting perception disorder: what do we know after 50 years. Drug Alcohol Depend 69: 109–119.
17. Hermle L. Fünfgeld M. Oepen G. Botsch H. Borchardt D. Gouzoulis E. (1992) Mescaline-induced psychopathological, neuropsychological and neurometabolic effects in male volunteers. Experimental psychosis as a tool for psychiatric research. Biol Psychiatry 32: 976–991.
18. Hermle L. Kovar K. Hewer W. Ruchsow M. (2008) Halluzinogen-induced psychological disorders. Fortschr Neuro Psychiat 76: 334–342.
19. Lerner A. Gelkopf M. Oyffe I. Finkel B. Katz S. Sigal M. (2000) LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. Int Clin Psychopharmacol 15: 35–37.
20. Lerner A. Gelkopf M. Skladman I. Rudinski D. Nachshon H. (2003) Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. Int Clin Psychopharmacol 18: 101–105.
21. Lerner A. Oyffe I. Isaacs G. Sigal M. (1997) Naltrexone treatment of hallucinogen persisting perception disorder. Am J Psychiatry 154: 437.
22. Lerner A. Shufman E. Kodesh A. Kretzmer G. Sigal M. (2002a) LSD-induced hallucinogen persisting perception disorder with depressive features treated with reboxetin: case report. Isr J Psychiatry Relat Sci 39: 100–103.
23. Lerner A. Shufman E. Kodesh A. Rudinski D. Kretzmer G. Sigal M. (2002b) Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse. Isr J Psychiatry Relat Sci 39: 57–60.
24. Lerner A. Skladman I. Kodesh A. Sigal M. Shufman E. (2001) LSD-induced hallucinogen persisting perception disorder treated with clonazepam: two case reports. Isr J Psychiatry Relat Sci 38: 133–136.
25. Markel H. Lee A. Holmes R. Domino E. (1994) LSD flashback syndrome exacerbated by elective serotonin reuptake inhibitor antidepressants in adolescents. J Pediatr 125: 817–819.
26. McGee R. (1984) Flashbacks and memory phenomena. A comment on ‘Flashback phenomena – clinical and diagnostic dilemmas’. J Nerv Ment Dis 172: 273–278.
27. Pechnik R. Ungerleider J. (2004) Hallucinogens. In: Lowinson J. Ruiz P. Milman R. Langrod J. (eds). Substance Abuse: A Comprehensive Textbook, 4th ed. Baltimore, MD: Lippincott Williams & Wilkins, pp. 313–323.
28. Sierra M. Phillips M. Ivin G. et al. (2003) A placebo-controlled crossover trial of lamotrigine in depersonalization disorder. J Psychopharmacology 17: 103–105.
29. Sierra M. Phillips M. Lambert M. et al. (2001) Lamotrigine in the treatment of depersonalization disorder. J Clin Psychiatry 62: 826–827.
30. Young C. (1997) Sertraline treatment of hallucinogen persisting perception disorder. J Clin Psychiatry 58: 85.